KAMADA LTD (KMDA)
IL0010941198 - Common Stock
KAMADA LTD
NASDAQ:KMDA (4/26/2024, 7:00:06 PM)
5.15
-0.05 (-0.96%)
Company Profile
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Company Info
KAMADA LTD
2 Holtzman St., Science Park
Rehovot 7670402
P: 97289406472
CEO: Amir London
Employees: 380
Website: https://www.kamada.com/
KMDA News
24 days ago - Market News VideoKamada Breaks Below 200-Day Moving Average - Notable for KMDA
2 months ago - InvestorPlaceKMDA Stock Earnings: Kamada Beats EPS, Misses Revenue for Q4 2023KMDA stock results show that Kamada beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
2 months ago - BusinessInsiderKMDA Stock Earnings: Kamada Beats EPS, Misses Revenue for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kamada (NASDAQ:KMDA) just reported results for the fourth quarter of 2023.Kamad...
REHOVOT, Israel, and HOBOKEN, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global...
Total Revenues for Fiscal Year 2023 of $142.5 Million, Representing All-Time Record Annual Revenues and Up 10% Compared to Fiscal Year 2022Fiscal Year 2023...
Company to Host Conference Call at 8:30am ET
KMDA Twits
Here you can normally see the latest stock twits on KMDA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
